High expression of some anti-apoptotic proteins, such as BCL2 family members, has also been suggested to contribute to stroma-mediated drug resistance in MM [21–23], especially MCL-1 which was demonstrated to be important in BMSC-mediated protection of MM cells against apoptosis [24]. This evidence concerns the gene MCL1 and Miyoshi myopathy.